Cargando…
Counteracting bone fragility with human amniotic mesenchymal stem cells
The impaired maturation of bone-forming osteoblasts results in reduced bone formation and subsequent bone weakening, which leads to a number of conditions such as osteogenesis imperfecta (OI). Transplantation of human fetal mesenchymal stem cells has been proposed as skeletal anabolic therapy to enh...
Autores principales: | Ranzoni, Anna M., Corcelli, Michelangelo, Hau, Kwan-Leong, Kerns, Jemma G., Vanleene, Maximilien, Shefelbine, Sandra, Jones, Gemma N., Moschidou, Dafni, Dala-Ali, Benan, Goodship, Allen E., De Coppi, Paolo, Arnett, Timothy R., Guillot, Pascale V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171815/ https://www.ncbi.nlm.nih.gov/pubmed/27995994 http://dx.doi.org/10.1038/srep39656 |
Ejemplares similares
-
Micro-computed tomography reconstructions of tibiae of stem cell transplanted osteogenesis imperfecta mice
por: Ranzoni, Anna M., et al.
Publicado: (2018) -
Ontological Differences in First Compared to Third Trimester Human Fetal Placental Chorionic Stem Cells
por: Jones, Gemma N., et al.
Publicado: (2012) -
TGFβ-induced osteogenic potential of human amniotic fluid stem cells via CD73-generated adenosine production
por: Hau, Kwan-Leong, et al.
Publicado: (2017) -
Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A
por: Vlahova, Filipa, et al.
Publicado: (2019) -
Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice()
por: Vanleene, Maximilien, et al.
Publicado: (2012)